PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,988 | -29.4% | 577,450 | -2.5% | 0.06% | -25.0% |
| Q2 2023 | $8,483 | +98.4% | 592,388 | -1.1% | 0.08% | +95.1% |
| Q1 2023 | $4,276 | -35.9% | 598,848 | +0.8% | 0.04% | -39.7% |
| Q4 2022 | $6,666 | -99.9% | 594,157 | +0.2% | 0.07% | -6.8% |
| Q3 2022 | $6,572,000 | +57.8% | 593,159 | +20.2% | 0.07% | +62.2% |
| Q2 2022 | $4,165,000 | -36.2% | 493,450 | +2.9% | 0.04% | -22.4% |
| Q1 2022 | $6,528,000 | -13.5% | 479,642 | +25.1% | 0.06% | -7.9% |
| Q4 2021 | $7,544,000 | +4.5% | 383,552 | +70.5% | 0.06% | -3.1% |
| Q3 2021 | $7,220,000 | -7.0% | 224,923 | -2.0% | 0.06% | -4.4% |
| Q2 2021 | $7,766,000 | +3.6% | 229,418 | +15.0% | 0.07% | -1.4% |
| Q1 2021 | $7,494,000 | – | 199,518 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,760,869 | $39,000,212 | 12.45% |
| Frazier Life Sciences Management, L.P. | 10,109,279 | $104,833,223 | 6.96% |
| Decheng Capital Management III (Cayman), LLC | 850,000 | $8,814,500 | 2.94% |
| Carlyle Group Inc. | 3,496,808 | $36,191,963 | 1.57% |
| Ghost Tree Capital, LLC | 395,000 | $4,096,150 | 1.35% |
| Newtyn Management, LLC | 500,000 | $5,185,000 | 1.28% |
| Altium Capital Management LP | 220,000 | $2,281,400 | 1.19% |
| StepStone Group LP | 422,085 | $4,377,021 | 0.98% |
| MPM BioImpact LLC | 347,332 | $3,601,833 | 0.96% |
| NEA Management Company, LLC | 1,276,595 | $12,238,290 | 0.94% |